Τόμος 5 (1991) – Τεύχος 3 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 5 (1991) – Issue 3 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Greek Military Pharmaceutical Laboratories of 441 ABYY, Athens, Greece

2. Welsh School of Pharmacy, University of Wales, College of Cardiff, Redwood Building, King Edward VII Avenue, P.O. Box 13, Cardiff CFI 3XF, U.K

Accepted for publication: 25 October 1991

pharmakonpress[at]pharmakonpress[.]gr

2.       Shinn, A.F. and Shrewsbury, R.P. (eds): Evaluation of drug interactions. American Pharmaceutical Association, 3rd edition, C.V. Mosby Co., 1985

3.       British Pharmacopoeia: Vol. II, H.M. Stationary Office, London, pp. 725-726, 916, A141-A144, 1988

4.       United States Pharmacopoeia, XXI Revision, Mack Easton, P.A., pp. 199, 1243-1244, 1985

5.       Swarbrick, J.: Current concepts in the Pharmaceutical Sciences: Biopharmaceutics, Lea and Febiger, Philadelphia, Chapter 6, pp. 265-296, 1970

6.       Ritschel, W.A.: Aspects for bioavailability and bioequivalence revision: possible implications on clinical pharmacology. Meih. Find. Exptl. Clin. Pharmacol. 9: 453 (1987}

7.       Muranishi, S.: Modification of intestinal absorption of drugs by lipoidal adjuvants. Pharm. Res. 2: 108 (1985)

8.       Kajii, H., Horie, T., Hayashi, M. and Awazu, S.: Effects of salicylic acid on the permeability of the plasma membrane of the small intestine of the rat: a fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption. J. Pharm. Sci. 75: 475 (1986)

9.       Martin, Y.C.: A practitioner’s perspective of the role of quantitative structure activity analysis in medicinal chemistry. J. Med. Chem. 24: 229 (1981)

10.     Taylor, D.C.: Intestinal drug absorption and controlled release. In: Development of Drugs in Modern Medicine (J.W. Gorrod, G.G. Gibson, M. Mitchard, eds), p. 361 (1986)

11.     Rooney, E.K., Gore, M.G., Lee, A.G.: Interaction of antihistamines with lipid bilayers. Biochem. Pharmacol., 28: 2199 (1979)

12.     Lee, A.G.: Spectroscopy in the study of drug-membrane interactions. T.I.P.S.: 145 (1982)

13.     Monkhouse, D.C., Lach, J.L.: Drug-excipient interactions. Can. J. Pharm. Sci. 7: 29 (1972)

14.     Temple, D.J.: Experimental models of drug interactions. In: Development of Drugs in Modern Medicine, (J.W. Gorrod, G.G. Gibson, M. Mitchard, eds), p. 543, 1986

15.     Schanker, L.S., Tocco, D.J., Brodie, B.B., Hogden, C.A.: Absorption of drugs from the rat small intestine. J. Pharmacol. Expt. Therap. 123: 81 (1958)

16.     D’Arcy, P.F., Muhyiddin, H.A., McElnay, J.C.: In vitro model of drug-metal ion interactions in the gut. J. Pharm. Pharmacol. 28: 33P (1976)

17.     Kessler, M., Acuto, O., Storelli, C., Murer, H., Muller, M., Semenzo, G.: A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. Biochim. Biophys. Acta 506: 136 (1978)

18.     McElnay, J.C., Temple, D.J.: The use of buccal partitioning as a model to examine the effects of aluminium hydroxide gel on the absorption of propranolol. Br. J. Clin. Pharmacol. 13: 399 (1982)

19.     Martin, A., Swarbrick, J., Cammarata, A.: Physical Pharmacy, 3rd edition, p. a) 325, b) 577, c) 473, d) 58, Lea and Febiger, Philadelphia, 1983

20.     Notari, R.E.: Biopharmaceutics and Clinical Pharmacokinetics, an Introduction. 3rd ed., p. 123, Marcel Dekker Inc., New York, 1980

21.     Barlow, O.W., Climenko, D.R.: Studies on the pharmacology of sulphapyridine and sulphathiazoie. J. Am. Med. Assoc. 116: 282 (1941)

22.     Peterson, O.L, Finland, M., Ballou, A.N.: The effect of food and alkali on the absorption and excretion of sulfonamide drugs after oral and duodenal administration. Am. J. Med. Sci. 204: 581 (1942)

23.     Feldman, S., Carlstedt, B.C.: Effect of antacid on absorption of enteric coated aspirin. J. Am. Med. Assoc. 227: 660 (1974)

24.     Lucarotti, R.L., Colaizzi, J.L, Barry, H„ Proust, R.I.: Enhanced pseudoephedrine absorption by concurrent administration of aluminium hydroxide gel in humans. J. Pharm. Sci. 61: 903 (1972)

25.     Johnson, C.E., Lloyd, C.W., Mesaros, J.L, Rudley, G.I.: Compatibility of aminophyltine and verapamil in intravenous admixtures. Am. J. Hosp. Pharm. 46: 97 (1989)

26.     Baker, D.E., Yost, G.S., Craig, V.L, Campbell, K.R.: Compatibility of heparin sodium and morphine sulphate. Am. J. Hosp. Pharm. 42: 1352 (1985)

27.     Nelson, E.: Comparative dissolution rates of weak acids and their sodium salts. J. Am. Pharm. Assoc. (Sci Ed.) 47: 297 (1958)

28.     Furesz, S.: Blood levels following oral administration of novobiocin. Antibiot. Chemother. 8: 446 (1958)

29.     Juncher, H., Raaschou, F.: Solubility of oral preparations of penicillin V. Antibiot. Med. C/in. Therapy. 4: 497 (1957)

30.     Nelson, E., Knoechel, E.L, Hamlin, W.E.: Influence of absorption rate of tolbutamide on the rate of decline of blood sugar levels in normal humans. J. Pharm. Sci. 51: 509 (1962)

31.     Anderson, K.W.: Oral absorption of quinolbarbitone and its sodium salt. Arch. Intern. Pharmacodyn. 147: 171 (1964)

32.     Hamza, Y.E., Paruta, A.N.: Enhanced solublity of paracetamol by various hydrotropic agents. Drug Dev. Ind. Pharm. 11: 1577 (1985)

33.     Aguiar, A.J., Wheeler, LM., Fusari, S., Zelmer, J.E.: Evaluation of physical and pharmaceutical factors involved in drug release and availability from chloramphenicol capsules. J. Pharm. Sci., 57: 1844 (1968)

34.     Glazko, A.J., Kinkel, A.W., Alegnani, W.C., Holmes, E.L.: An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects. Clin. Pharmacol. Ther. 9: 472 (1968)

35.     Bell, H., Johansen, H., Lunde, P.K.M., Andersgaard, H.A., Sin holt. P., Midtvedt, T., Hollum, E.: Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations in healthy human male subjects. Pharmacology 5: 108 (1971)

36.     Georgarakis, M., Hatzipantou. P., Kountourelis, J.E.: Effect of particle size, content in lubricant, mixing time and storage relative humidity on drug release from hard gelatin ampicillin capsules. Drug Dev. Ind. Pharm. 14: 915 (1988)

37.     Johnson, B.F., Fowle, A.S.E., Lader, S., Fox, J., Munro-Faure, A.D.: Biological activity of digoxin from Lanoxin produced in the United Kingdom. Br. Med. J. 4: 323

(1973)

38.     Khalil, S.A., Moustafa, M.A., Ebian, A.R., Motawi, M.M.: G.l. absorption of two crystal forms of sulfameter in man. J. Pharm. Sci 61: 1615 (1972)

39.     Menachemoff. E.: The absorption of chloramphenicol palmitate. Harokeach Haivri 10: 189 (1964) (Chem. Abstr. 63: 6180g).

40.     Craven, B.M., Vizzini, E.A.: Crystal structures of two polymorphs of 5-ethyl-5-isoamylbarbituric acid (amobarbital). Acta Cyst. B25: 1993 (1969)

41.     Robertson, J.M.: Structure of resorcinol, a quantitative X-ray investigation. Proc. Roy. Soc. A157: 79 (1936)

42.     Alleaume, M., Decap, J.: Tridimensional refinement of sulfanilamide. Acta Cryst. 19: 934 (1965)

43.     Bettinetti, G.P., Giordano, F., La Manna, A., Giuseppetti, G., Tadini, C.: Solid state molecular arrangements of sulfamethoxazole C₁₀H₁₁N₂O₃S: the crystal structure of two polymorphs. Cryst. Struct. Comm.. 11: 821 (1982)

44.     Kruger, G.J., Gafner, G.: Crystal structure of polymorphs I and III of sulfathiazole. Acta Cryst. B28: 111 (1972)

45.     Azibi, M., Draguet-Brughmans, M„ Bouche, R., Tinant, B., Germain, G., Declerq, J.P., Van Meerssche, M.: Conformational study of two polymorphs of spiperone: possible consequences on the interpretation of pharmacological activity. J. Pharm. Sci. 72: 232 (1983)

46.     Poole, J.W., Bahai, C.K.: Dissolution behaviour and solubility of anhydrous and trihydrate forms of ampicillin. J. Pharm. Sci. 57: 1945 (1968)

47.     Ballard, B.E., Biles, J.A.: Effect of crystallizing solvent on absorption rates of steroid implants. Steroids 4: 273 (1964)

48.     Armstrong, N.A., James, K.C.: Drug release from lipid dosage forms I. Int. J. Pharmaceut. 6: 185 (1980)

49.     Armstrong, N.A., James, K.C.: Drug release from lipid dosage forms II. Int. J. Pharmaceut., 6: 195 (1980)

50.     Bates, T.R., Sequeira, J.A.: Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans. J. Pharm. Sci. 64: 793 (1975}

51.     Tokumura, T., Tsushima, Y., Tatsuishi, K., Kayano, M., Machida, Y., Naqai, T.: Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. J. Pharm. Sci. 76: 286 (1987)

52.     Hofmann, A.F., Brogstrom, B.J.: The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phase of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. 43: 247 (1964)

53- Mulley, B.A.: Solubility in systems containing surface active agents. In: Bean, H.S., Beckett, A.H., Casrless, J.E. (eds). Advan. Pharm. Sci., Academic Press, New York, 1: 186 (1964)

54.     Elworthy, P.H., Florence, A.T., Macfarlane, C.B.: Solubilization by surface active agents. Chapman and Hall, London, 1968

55.     Chiou, W.L., Riegelman, S.: Griseofulvinoral absorption in dogs; increased absorption via solid dispersions. J. Pharm. Sci. 59: 937 (1970)

56.     Lauwo, J.A.K.: Effect of particle size and excipients on the dissolution rate of metronidazole from solid dosage forms: I. Drug Dev. Ind. Pharm. 11: 1565 (1985)

57.     Devani, M.B., Shishoo, C.J., Doshi, K.J., Patel, H.B.: Kinetic studies of the interaction between isoniazid and reducing sugars. J. Pharm. Sci., 74: 427 (1985)

58.     Chowman, Z.T., Chi, L.H.: Drug-excipient interactions resulting from powder mixing. Ill solid-stage properties and their effect on drug dissolution. J. Pharm. Sci. 75: 534 (1986)

59.     Silver, B., Sundholm, E.G.: Solid state esterification of codeine phosphate by the acid constituent of effervescent tablets. J. Pharm. Set. 76: 53 (1987)

60.     Prescott, L.F.: Pharmacokinetic drug interactions. Lancet ii: 1239 (1969)

61.     Sandmann, B.J., Luk, H.T.: A potentiometric study of lithium complexation with catecholamines. J. Pharm. Sci. 75: 73 (1986)

62.     Martell, A.E., Calvin, M.: Chemistry of the Metal Chelate Compound. Prentice Hall, New York, p. 54, 1952

63.     Ambre, J.J., Fuher, L.T.: Effect of coadministration of aluminium and magnesium hydroxides on absorption of anticoagulants in man. CUn. Pharmacokinet. Ther. 14: 231 (1973)

64.     Bighley, L.D., Spirey, R.J.: Chelates of dicumarol. I: Preparation and structure identification of magnesium chelate. J. Pharm. Sei. 66: 1123 (1977)

65.     E.A. Rawlins (ed.): Bentley’s Textbook of Pharmaceutics, 8^th ed., Bailliere Tindall, London, 1977

66.     Nogrady, T.: Medicinal Chemistry, a Biochemical Approach, p. 43, Oxford University Press, New York,

1988

67.     Gassim, A.E.H., Takla, P.G., James, K.C.: Ultraviolet spectrophotometry for the determination of benperidol by a difference procedure and for the elucidation of its polymorphic structure. Analyst 11: 923 (1986)

68.     Plaizier-Vercammen, J.A.: Interaction of povidone with aromatic compounds VI: Use of partition coefficients (log kd) to correlate with log P values and apparent kd values to express the binding as a function of pH and pKa. J. Pharm. Sci. 76: 817 (1987)

69.     El-Hinnawi, M.A., Najrb, N.M.: Ibuprofen-polyvinylpyrrolidone dispersions. Proton nuclear magnetic resonance and infrared studies. Int. J. Pharmaceut. 37: 175 (1987)

70.     Doherty, C., York, P.: Evidence for solid and liquid state interactions in a furosemide-polyvinylpyrrol done solid dispersion. J. Pharm. Sei. 76: 731 (1987)

71.     De Taeye, J., Zeegers-Huyskens, Th.: Infrared study of the interaction between caffeine and hydroxylic derivatives. J. Pharm. Sei. 74: 660 (1985)

72.     Mattha, A.G., Ammar, H.O., Abdel-Samie, M., El-Nahhas,

S.A., Kassem, M.A.: Complex formation between anti- histaminic drugs and caffeine. Pharm. Acta Helv., 57: 268 (1982)

73.     Florence, A.T., Attwood, D.: Physicochemical Principles of Pharmacy, 2nd ed., a) p. 427, b) p. 429, c) p. 350, The MacMillan Press Ltd., London, 1988

74.     Kenley, R.A., Jackson, S.E., Winterle, J.S., Shunko, Y., Visor, G.C.: Water soluble complexes of the antiviral drugs, 9-[(1,3-dihydroxy-2-propoxy)methyl] guanine and acyclovir: the role of hydrophobicity in complex formation. J. Pharm. Sci., 75: 648 (1986)

75.     James, K.C.: Solubility and related properties. In: Drug and the Pharmaceutical Sciences, (J. Swarbrick, ed.). Vol. 28, p. 93, 113, Marcel Dekker, New York, 1986

76.     Bender, M.L., Komiyama, M.: Cyclodextrrn Chemistry, Springler-Verlag, Berlin, 1978

77.     Szsjtli, J.: Cyclodextrins and their inclusion complexes, Budapest, Akademial Kiado, Budapest, 1982

78.     Uekama, K., Fujinaga, T., Hirayama, F., Otagiri, M.,Yamasaki, M., Seo, H., Hashimoto, T., Tsucuoka, M.: Improvement of oral bioavailability of digitalis glycosides by cyclodextrim complexation. J. Pharm. Sci. 72: 1338 (1983)

79.     Uekama, K., Imai, T., Maeda, T., Irie, T., Hirayama, F., Otagiri, M.: Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis (2,6 di-0-methyl)-ß-cyciodextrin. J. Pharm. Set. 74: 841 (1985)

80.     Compendium of Pharmaceuticals and Specialties, 20^th ed., p. 586, Ottawa, Canadian Pharmaceutical Association, 1985

81.     Brown, D.D., Juhl, R.P., Warner, S.L.: Effect of hypocholesterolemic interventions on digoxin bioavailability. Drug Met ab. Rev., 9: 107 (1979)

82.     Parsons, R.L., Paddock, G.M.: Absorption of two antibacterial drugs, cephalexin and cotrimoxazole, in malabsorption syndromes. J. Antimicrob. Chemother., (Suppl): 59 (1975)

83.     Nortcutt, R.C., Stiel, J.N., Hollifield, J.W., Stant, E.G. Jr.: The influence of cholestyramine on thyroxine absorption. J. Am. Med. Assoc., 208: 1857 (1969)

84.     Robinson, D.S., Benjamin, D.M., McCormack, J.J.: Interaction of warfarin and non-systemic gastrointestinal drugs. Clin. Pharmacol. Ther. 12: 491 (1971)

85.     Bowman, W.C., Rand, M.J.: Textbook of Pharmacology, 2^nd ed., Ch. 28, p. 28, Blackwell Scientific Publications, Oxford, 1980

86.     Rugendorff, E.W., Schneider, H.J.: Cation exchange resin preparation in recurrent calcium urolithiasis. Urology, 22: 143 (1983)

87.     Sawaya, A., Benort, J.P., Benita, S.: Binding mechanism of doxorubicin in ion-exchange microcapsules. J. Pharm. Sci. 76: 475 (1987)

88.     Wagner, J.G.: Design and data analysis of biopharma ceutical studies in man. Can. J. Pharm. Sci. 1: 55 (1966)

89.     Hosny, E.A., Kassem, A., El-Shattawy, H.H.: Availability of anhydrous ampicillin and sulpiadimidine from their suspensions. Drug Dev. Ind. Pharm. 14: 779 (1988)

90.     Albert, K.S., Ayres, J.W., Di Santo, A.R., Weidler, D.J., Sakmar, E., Hallmark, M.R., Stoll, R.G., De Sante, K.A., Wagner, J.G.: Influence of kaolin-pectin suspension of digoxin bioavailability. J. Pharm. Sci. 67: 1582 (1978)

91.     Gouda, M.W.: Effect of an antidiarrheal mixture on the bioavailability of tetracycline and ampicillin. Ac. Pharm. Sci. (Abstracts of 21st Meet.), 6: 117 (1976)

92.     Corby, D.G., Decker, W.J.: Management of acute poisoning with activated charcoal. Pediatrics, 54: 324 (1974)

93.     Hayden, J.W., Comstock, E.G.: Use of activated charcoal in acute poisoning. Clin. Toxicol. 8: 515 (1975)

94.     Neunoven, P.J., Elfring, S.M., Elonen, E.: Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur. J. Clin. Pharmacol. 13: 213 (1978)

95.     Rybolt, T.R., Burrell, D.E., Shults, J.M., Kelley, A.K.: In vitro coadsorption of acetaminophen and N-acetyl-cysteine onto activated carbon powder. J. Pharm. Sci. 75: 904 (1986)

96.     Neunoven, P.J.: Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin. Pharmacokinet. 7: 465 (1982)

97.     Morishita, T., Yamazaki, M., Yata, N., Kamada, A.: Studies on absorption of drugs. VIII. Physicochemical factors affecting the absorption of sulfonamides form the rat small intestine. Chem. Pharm. Bull., 21: 2309 (1973)

98.     Abe, I., Kamaya, H., Ueda, I.: Activated carbon as a biological model: comparison between activated carbon absorption and oil-water partition coefficient for drug activity correlation. J. Pharm. Sci. 77: 166 (1988)

99.     Mesiha, M.S., Shawky, S.: Adsorption of some 1,4 benzodiazepines on insoluble tablet excipients and charcoal. Drug Dev. Ind. Pharm. 14: 939 (1988)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr